A cosmetic treatment based on SCA® PRO 40% improves clinical results after use of non-ablative traditional laser in skin aging.

Materials and methods

TWO STUDIES were conducted to evaluate efficacy after the use of a fractional non-ablative laser and a fractional ablative laser.

  • Vehicle-controlled, double-blind, prospective study.
  • Patients aged 45-65 years.
  • Each patient had SCA® 40 applied to one side of the face and the vehicle to the other.
  • 20 and 10 patients, respectively, with moderate photoaging.

Treatment regimen

*Two sessions were conducted with the fractional non-ablative 1540 nm Erbium Glass laser using 50 mJ of energy with a pulse duration of 15 ms. The laser was passed over the patient’s face three times at each session.

**The product was applied immediately after the laser session and over the 28-day study period. The ampoules were applied every 12 hours for the first 7 days after the laser session and then every 24 hours until the following laser session. The patients also used topical sunscreen.

Clinical course



Applying a cosmetic protocol formulated with SCA® 40 (Cryptomphalus aspersa secretion) immediately after laser procedures such as a fractional non-ablative laser and ablative CO2 laser and over the following days can accelerate cutaneous healing after the damage caused by the laser, significantly reduce the associated adverse effects, and improve procedure results, making it a valuable tool for skincare specialists. SCA® 40 should be used following laser skin procedures to ensure maximum compliance and patient satisfaction.